Teicoplanin Allergy Testing Using Autologous Serum (TATAS)

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Drug Allergy
Interventions
DIAGNOSTIC_TEST

Teicoplanin Allergy Testing using autologous serum

"In addition to performing teicoplanin allergy skin testing using standard recommended Teicoplanin concentration, we will perform skin testing using autologous serum, the supernatant which is obtained via centrifugation. Skin testing ( skin prick test and intradermal test) will be performed with these additional samples:~1. STpre: Teicoplanin added to blood sample pre-centrigufation.~2. STpost: Teicoplanin added to supernatant post-centrigufation.~3. ST0: Supernatant with no additives ( serum negative control)"

Trial Locations (1)

SO16 6YD

RECRUITING

University Hospital Southampton, Southampton

All Listed Sponsors
lead

University Hospital Southampton NHS Foundation Trust

OTHER